

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.52356455 |
| 2 | cytidine catabolic process (GO:0006216) | 9.52356455 |
| 3 | cytidine deamination (GO:0009972) | 9.52356455 |
| 4 | DNA deamination (GO:0045006) | 8.82577194 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.37487508 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.02827663 |
| 7 | negative regulation by host of viral transcription (GO:0043922) | 4.41032062 |
| 8 | protein neddylation (GO:0045116) | 4.29636137 |
| 9 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.23895872 |
| 10 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.16050745 |
| 11 | eosinophil chemotaxis (GO:0048245) | 4.06155061 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.01488322 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.01256323 |
| 14 | proteasome assembly (GO:0043248) | 3.94927401 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.79964229 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.77380714 |
| 17 | actin nucleation (GO:0045010) | 3.75513470 |
| 18 | T cell migration (GO:0072678) | 3.75055303 |
| 19 | negative regulation of T cell apoptotic process (GO:0070233) | 3.73402771 |
| 20 | positive T cell selection (GO:0043368) | 3.70205945 |
| 21 | eosinophil migration (GO:0072677) | 3.67188226 |
| 22 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.59355300 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.56138848 |
| 24 | ATP synthesis coupled proton transport (GO:0015986) | 3.56096362 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.56096362 |
| 26 | negative regulation of viral genome replication (GO:0045071) | 3.52134530 |
| 27 | DNA demethylation (GO:0080111) | 3.51503595 |
| 28 | respiratory electron transport chain (GO:0022904) | 3.47392651 |
| 29 | DNA dealkylation (GO:0035510) | 3.44688498 |
| 30 | electron transport chain (GO:0022900) | 3.42521788 |
| 31 | platelet dense granule organization (GO:0060155) | 3.38748877 |
| 32 | cytolysis (GO:0019835) | 3.37754129 |
| 33 | regulation of interleukin-8 secretion (GO:2000482) | 3.34064621 |
| 34 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.33361803 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29562475 |
| 36 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.28309279 |
| 37 | positive regulation of defense response to virus by host (GO:0002230) | 3.21319354 |
| 38 | negative T cell selection (GO:0043383) | 3.21186387 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.20256211 |
| 40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.20256211 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.19327996 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.19327996 |
| 43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.19327996 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 3.15792174 |
| 45 | regulation of activation of Janus kinase activity (GO:0010533) | 3.13486053 |
| 46 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.11748985 |
| 47 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.10119155 |
| 48 | sequestering of actin monomers (GO:0042989) | 3.08665519 |
| 49 | negative regulation of B cell proliferation (GO:0030889) | 3.08121924 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.05808422 |
| 51 | signal peptide processing (GO:0006465) | 3.05451673 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.03785241 |
| 53 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.01346182 |
| 54 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.00695179 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00365223 |
| 56 | negative regulation of ligase activity (GO:0051352) | 2.97816579 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.97816579 |
| 58 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97731039 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.97731039 |
| 60 | regulation of chronic inflammatory response (GO:0002676) | 2.97013204 |
| 61 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.96334536 |
| 62 | positive regulation of lymphocyte migration (GO:2000403) | 2.96157209 |
| 63 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.93215504 |
| 64 | regulation of B cell differentiation (GO:0045577) | 2.91903228 |
| 65 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.91758608 |
| 66 | macrophage chemotaxis (GO:0048246) | 2.90022918 |
| 67 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.86524743 |
| 68 | protein complex biogenesis (GO:0070271) | 2.85713310 |
| 69 | cytochrome complex assembly (GO:0017004) | 2.85154358 |
| 70 | respiratory chain complex IV assembly (GO:0008535) | 2.83668845 |
| 71 | T cell costimulation (GO:0031295) | 2.81766119 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.81472547 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81020664 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78652258 |
| 75 | lymphocyte costimulation (GO:0031294) | 2.78551703 |
| 76 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.75640549 |
| 77 | regulation of calcium-mediated signaling (GO:0050848) | 2.73214228 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.72417833 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70798736 |
| 80 | response to interferon-beta (GO:0035456) | 2.69570676 |
| 81 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.69546241 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 2.68828965 |
| 83 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.67376052 |
| 84 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.65916833 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.65570062 |
| 86 | piRNA metabolic process (GO:0034587) | 2.64495371 |
| 87 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.64082721 |
| 88 | regulation of cellular amine metabolic process (GO:0033238) | 2.63989077 |
| 89 | positive regulation of cell cycle arrest (GO:0071158) | 2.63867918 |
| 90 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.62890501 |
| 91 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.62890501 |
| 92 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.62852197 |
| 93 | regulation of viral genome replication (GO:0045069) | 2.60733893 |
| 94 | positive regulation of T cell chemotaxis (GO:0010820) | 2.59468810 |
| 95 | regulation of T cell chemotaxis (GO:0010819) | 2.59468810 |
| 96 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.58908200 |
| 97 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.58037051 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57892690 |
| 99 | positive regulation of ligase activity (GO:0051351) | 2.57466116 |
| 100 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.57419093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.20745223 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.66402884 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.19957548 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13228389 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.07154390 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00069930 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74191282 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72895765 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.60106332 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59897593 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55823239 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.27715541 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22512133 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.21733370 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.16615665 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.14056831 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.13217211 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08598272 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04276308 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.02591574 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95843319 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.91306762 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.88220128 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83409413 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77004783 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.74303920 |
| 27 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.73506272 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68640568 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.65582522 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62274258 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56433220 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56316439 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55963528 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55709023 |
| 35 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47839323 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47292634 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45299429 |
| 38 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.43875779 |
| 39 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.43875779 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43457641 |
| 41 | AR_20517297_ChIP-Seq_VCAP_Human | 1.43296438 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42853371 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41900861 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39905880 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39083912 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38055457 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36948096 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33475001 |
| 49 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33475001 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31146865 |
| 51 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30192250 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29900797 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29463516 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28690439 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26212896 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24990375 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24563330 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24144112 |
| 59 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24111786 |
| 60 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22333406 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21306380 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19173570 |
| 63 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.18270858 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16753853 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16159219 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15280373 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15275779 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15041440 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14404111 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14175720 |
| 71 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12021344 |
| 72 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11828725 |
| 73 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.10257911 |
| 74 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.10081523 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09989578 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09526859 |
| 77 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.07708451 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07139784 |
| 79 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07139784 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.06104552 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05427307 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03648994 |
| 83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03060842 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02005289 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01977475 |
| 86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99357833 |
| 87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98897159 |
| 88 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98638553 |
| 89 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98424316 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97473833 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 0.95254172 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93548196 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93089656 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92741368 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92400968 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90677278 |
| 97 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90382293 |
| 98 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.88189282 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88027579 |
| 100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87985586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.98915945 |
| 2 | MP0009785_altered_susceptibility_to | 2.73601109 |
| 3 | MP0002102_abnormal_ear_morphology | 2.71748933 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.56683685 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.38629085 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 2.35673480 |
| 7 | MP0003646_muscle_fatigue | 2.33979986 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.25810429 |
| 9 | MP0004147_increased_porphyrin_level | 2.20889525 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.19387852 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.04876085 |
| 12 | MP0003195_calcinosis | 2.03829486 |
| 13 | MP0001800_abnormal_humoral_immune | 1.96567594 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 1.91550787 |
| 15 | MP0005360_urolithiasis | 1.87828707 |
| 16 | MP0001919_abnormal_reproductive_system | 1.83904146 |
| 17 | MP0001968_abnormal_touch/_nociception | 1.76630024 |
| 18 | MP0002420_abnormal_adaptive_immunity | 1.75839012 |
| 19 | MP0002723_abnormal_immune_serum | 1.75723231 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.73598741 |
| 21 | MP0001790_abnormal_immune_system | 1.73041454 |
| 22 | MP0005387_immune_system_phenotype | 1.73041454 |
| 23 | MP0001905_abnormal_dopamine_level | 1.69951929 |
| 24 | MP0008877_abnormal_DNA_methylation | 1.69525123 |
| 25 | MP0001819_abnormal_immune_cell | 1.68772700 |
| 26 | MP0005025_abnormal_response_to | 1.66665910 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 1.63891529 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.63444879 |
| 29 | MP0008872_abnormal_physiological_respon | 1.60601812 |
| 30 | MP0006082_CNS_inflammation | 1.58191072 |
| 31 | MP0005253_abnormal_eye_physiology | 1.57912714 |
| 32 | MP0003045_fibrosis | 1.56768916 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.56734428 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.55228027 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.52588131 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.49424100 |
| 37 | MP0003011_delayed_dark_adaptation | 1.48916595 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.48089499 |
| 39 | MP0002736_abnormal_nociception_after | 1.47008084 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.45047518 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.43718466 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.42832676 |
| 43 | MP0005389_reproductive_system_phenotype | 1.41250304 |
| 44 | MP0003866_abnormal_defecation | 1.39343907 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.39182468 |
| 46 | MP0002006_tumorigenesis | 1.37726601 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.31357292 |
| 48 | MP0000716_abnormal_immune_system | 1.29965041 |
| 49 | MP0002398_abnormal_bone_marrow | 1.28270287 |
| 50 | MP0003880_abnormal_central_pattern | 1.27064953 |
| 51 | MP0000685_abnormal_immune_system | 1.24931213 |
| 52 | MP0009745_abnormal_behavioral_response | 1.23534380 |
| 53 | MP0001873_stomach_inflammation | 1.23417755 |
| 54 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21907781 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.20823400 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.19250367 |
| 57 | MP0003786_premature_aging | 1.17927505 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.16995000 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.14338034 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.14064462 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.13645515 |
| 62 | MP0004043_abnormal_pH_regulation | 1.12807632 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.12196191 |
| 64 | MP0005410_abnormal_fertilization | 1.10499974 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.06363832 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.06003676 |
| 67 | MP0002933_joint_inflammation | 1.04866443 |
| 68 | MP0001970_abnormal_pain_threshold | 1.03361544 |
| 69 | MP0002693_abnormal_pancreas_physiology | 1.02161310 |
| 70 | MP0002405_respiratory_system_inflammati | 1.02071989 |
| 71 | MP0000372_irregular_coat_pigmentation | 1.01649327 |
| 72 | MP0010386_abnormal_urinary_bladder | 1.01301511 |
| 73 | MP0003448_altered_tumor_morphology | 1.00507951 |
| 74 | MP0002722_abnormal_immune_system | 1.00396550 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.99029658 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.95253713 |
| 77 | MP0002429_abnormal_blood_cell | 0.94759223 |
| 78 | MP0001984_abnormal_olfaction | 0.94081169 |
| 79 | MP0002272_abnormal_nervous_system | 0.93644869 |
| 80 | MP0000427_abnormal_hair_cycle | 0.93487390 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.93360309 |
| 82 | MP0001542_abnormal_bone_strength | 0.90301422 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 0.89124795 |
| 84 | MP0003724_increased_susceptibility_to | 0.89080170 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.88827028 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.85327765 |
| 87 | MP0004142_abnormal_muscle_tone | 0.83093709 |
| 88 | MP0009763_increased_sensitivity_to | 0.82647679 |
| 89 | MP0002419_abnormal_innate_immunity | 0.82505589 |
| 90 | MP0005646_abnormal_pituitary_gland | 0.82276132 |
| 91 | MP0002163_abnormal_gland_morphology | 0.80106989 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.78641347 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.77424983 |
| 94 | MP0009764_decreased_sensitivity_to | 0.77091130 |
| 95 | MP0006292_abnormal_olfactory_placode | 0.76781509 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.76352139 |
| 97 | MP0001853_heart_inflammation | 0.75363501 |
| 98 | MP0008469_abnormal_protein_level | 0.74986267 |
| 99 | MP0003075_altered_response_to | 0.73766647 |
| 100 | MP0002168_other_aberrant_phenotype | 0.73177834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 5.09596835 |
| 2 | Congenital stationary night blindness (HP:0007642) | 4.24061101 |
| 3 | Hypoproteinemia (HP:0003075) | 4.00448637 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.84957785 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.75479708 |
| 6 | Abnormality of T cell number (HP:0011839) | 3.73480324 |
| 7 | T lymphocytopenia (HP:0005403) | 3.72898151 |
| 8 | IgG deficiency (HP:0004315) | 3.72332751 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 3.69088136 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.67173880 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.58744387 |
| 12 | Abnormality of the prostate (HP:0008775) | 3.51055675 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.42052609 |
| 14 | Increased CSF lactate (HP:0002490) | 3.38288317 |
| 15 | Hepatic necrosis (HP:0002605) | 3.37496335 |
| 16 | Thyroiditis (HP:0100646) | 3.24833155 |
| 17 | Acute encephalopathy (HP:0006846) | 3.20925950 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.18072553 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.15150995 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.13879707 |
| 21 | Abnormality of T cells (HP:0002843) | 2.90348685 |
| 22 | Agammaglobulinemia (HP:0004432) | 2.83461786 |
| 23 | Combined immunodeficiency (HP:0005387) | 2.79067153 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.77217708 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.77217708 |
| 26 | Pancreatic cysts (HP:0001737) | 2.76209025 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.71926938 |
| 28 | Renal cortical cysts (HP:0000803) | 2.69596508 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.66971944 |
| 30 | Abolished electroretinogram (ERG) (HP:0000550) | 2.64442576 |
| 31 | Methylmalonic aciduria (HP:0012120) | 2.61492553 |
| 32 | Increased IgM level (HP:0003496) | 2.56984102 |
| 33 | Hypoplasia of the thymus (HP:0000778) | 2.56190792 |
| 34 | Abnormality of eosinophils (HP:0001879) | 2.54271546 |
| 35 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.54073624 |
| 36 | Chronic diarrhea (HP:0002028) | 2.51414614 |
| 37 | Methylmalonic acidemia (HP:0002912) | 2.50733167 |
| 38 | Pancreatic fibrosis (HP:0100732) | 2.49905314 |
| 39 | Decreased central vision (HP:0007663) | 2.42539929 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 2.42410890 |
| 41 | Molar tooth sign on MRI (HP:0002419) | 2.42410890 |
| 42 | Pancytopenia (HP:0001876) | 2.40919849 |
| 43 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38744799 |
| 44 | True hermaphroditism (HP:0010459) | 2.35599112 |
| 45 | Hypoalbuminemia (HP:0003073) | 2.32607262 |
| 46 | Abnormal albumin level (HP:0012116) | 2.32607262 |
| 47 | Abnormality of the renal cortex (HP:0011035) | 2.31777204 |
| 48 | Encephalitis (HP:0002383) | 2.30983542 |
| 49 | Lethargy (HP:0001254) | 2.30649445 |
| 50 | Cerebral edema (HP:0002181) | 2.30532811 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.29969737 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.28899427 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.27149774 |
| 54 | Increased serum lactate (HP:0002151) | 2.26666022 |
| 55 | Eosinophilia (HP:0001880) | 2.25718902 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.24188431 |
| 57 | Lactic acidosis (HP:0003128) | 2.22009164 |
| 58 | Stomatitis (HP:0010280) | 2.19365513 |
| 59 | Hyperglycinemia (HP:0002154) | 2.18429374 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.17920557 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17920557 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.17529960 |
| 63 | Renal Fanconi syndrome (HP:0001994) | 2.16380333 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.15273415 |
| 65 | Increased muscle lipid content (HP:0009058) | 2.14484404 |
| 66 | Congenital, generalized hypertrichosis (HP:0004540) | 2.13109927 |
| 67 | Prostate neoplasm (HP:0100787) | 2.11783276 |
| 68 | Optic disc pallor (HP:0000543) | 2.11768148 |
| 69 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10840923 |
| 70 | Ketoacidosis (HP:0001993) | 2.10320420 |
| 71 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10308233 |
| 72 | Meningitis (HP:0001287) | 2.09419756 |
| 73 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09144752 |
| 74 | Hypothermia (HP:0002045) | 2.07896455 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.06708953 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 2.06708953 |
| 77 | Hyperalaninemia (HP:0003348) | 2.06708953 |
| 78 | Oral leukoplakia (HP:0002745) | 2.00900756 |
| 79 | Respiratory failure (HP:0002878) | 1.98728108 |
| 80 | Ketosis (HP:0001946) | 1.98281212 |
| 81 | IgM deficiency (HP:0002850) | 1.95513234 |
| 82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94910949 |
| 83 | B lymphocytopenia (HP:0010976) | 1.91080693 |
| 84 | CNS demyelination (HP:0007305) | 1.90760140 |
| 85 | Abnormality of male internal genitalia (HP:0000022) | 1.89707674 |
| 86 | Exercise intolerance (HP:0003546) | 1.84886201 |
| 87 | Chronic sinusitis (HP:0011109) | 1.84281433 |
| 88 | Leukocytosis (HP:0001974) | 1.82896366 |
| 89 | Severe visual impairment (HP:0001141) | 1.80497906 |
| 90 | Joint swelling (HP:0001386) | 1.80397155 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 1.79387907 |
| 92 | Hemiplegia (HP:0002301) | 1.77205608 |
| 93 | Palpebral edema (HP:0100540) | 1.75476188 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 1.75147710 |
| 95 | Keratoconus (HP:0000563) | 1.73654200 |
| 96 | Increased corneal curvature (HP:0100692) | 1.73654200 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73058710 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.73056617 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72799397 |
| 100 | Obstructive lung disease (HP:0006536) | 1.72799397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 6.32348967 |
| 2 | TXK | 5.41558564 |
| 3 | KDR | 4.13715520 |
| 4 | FRK | 2.51797225 |
| 5 | VRK2 | 2.49693680 |
| 6 | GRK1 | 2.46854060 |
| 7 | MST4 | 2.45747320 |
| 8 | BMPR1B | 2.27313613 |
| 9 | ITK | 2.22220622 |
| 10 | BCKDK | 2.12009029 |
| 11 | TAOK3 | 1.89673518 |
| 12 | ADRBK2 | 1.87660278 |
| 13 | NUAK1 | 1.85637138 |
| 14 | LIMK1 | 1.72425859 |
| 15 | MAP4K1 | 1.61509911 |
| 16 | TESK1 | 1.59507234 |
| 17 | BUB1 | 1.53996831 |
| 18 | EIF2AK3 | 1.49250792 |
| 19 | MAP4K2 | 1.48567871 |
| 20 | MAP3K12 | 1.45901910 |
| 21 | STK16 | 1.42902440 |
| 22 | FES | 1.42608511 |
| 23 | MUSK | 1.33388776 |
| 24 | ZAK | 1.31894359 |
| 25 | SYK | 1.29244872 |
| 26 | MAPK13 | 1.23379395 |
| 27 | VRK1 | 1.22240982 |
| 28 | PRKCQ | 1.19949021 |
| 29 | MAPKAPK3 | 1.19853587 |
| 30 | INSRR | 1.16476611 |
| 31 | TEC | 1.13374549 |
| 32 | MYLK | 1.11735559 |
| 33 | PIK3CA | 1.11405906 |
| 34 | WNK4 | 1.07086631 |
| 35 | WNK3 | 1.02838728 |
| 36 | TLK1 | 1.00366186 |
| 37 | EIF2AK1 | 0.97246188 |
| 38 | BCR | 0.89528501 |
| 39 | IKBKB | 0.88289054 |
| 40 | CSK | 0.87990276 |
| 41 | LCK | 0.87240546 |
| 42 | PINK1 | 0.85162262 |
| 43 | LYN | 0.79601752 |
| 44 | MAP2K6 | 0.79068103 |
| 45 | KIT | 0.78999024 |
| 46 | CDK8 | 0.78383963 |
| 47 | IKBKE | 0.75191526 |
| 48 | PLK2 | 0.75112729 |
| 49 | STK38L | 0.74438783 |
| 50 | GRK7 | 0.74329954 |
| 51 | ERBB3 | 0.74000492 |
| 52 | MAP3K11 | 0.73272004 |
| 53 | DAPK1 | 0.72473176 |
| 54 | CSF1R | 0.72413385 |
| 55 | MAP2K7 | 0.71284006 |
| 56 | CCNB1 | 0.65794854 |
| 57 | TRIM28 | 0.63882026 |
| 58 | DAPK2 | 0.62977688 |
| 59 | CASK | 0.58326215 |
| 60 | STK39 | 0.57715747 |
| 61 | PIK3CG | 0.56919079 |
| 62 | PIM2 | 0.55183871 |
| 63 | SRPK1 | 0.53619784 |
| 64 | ROCK1 | 0.53304726 |
| 65 | OXSR1 | 0.53255411 |
| 66 | IGF1R | 0.51879661 |
| 67 | TYRO3 | 0.50472151 |
| 68 | PRKCE | 0.48298807 |
| 69 | OBSCN | 0.48150146 |
| 70 | NME1 | 0.47830811 |
| 71 | CAMK2A | 0.47652304 |
| 72 | DYRK2 | 0.47016428 |
| 73 | BTK | 0.46368257 |
| 74 | RPS6KA5 | 0.45620274 |
| 75 | PRKCA | 0.44434045 |
| 76 | TIE1 | 0.44430204 |
| 77 | ZAP70 | 0.44311311 |
| 78 | TNK2 | 0.43278512 |
| 79 | TAF1 | 0.42517584 |
| 80 | FLT3 | 0.41647637 |
| 81 | PRKACA | 0.40522735 |
| 82 | ARAF | 0.40465984 |
| 83 | TBK1 | 0.39953876 |
| 84 | PRKCG | 0.38701747 |
| 85 | ACVR1B | 0.38525626 |
| 86 | ADRBK1 | 0.38350907 |
| 87 | FYN | 0.37640133 |
| 88 | MARK3 | 0.36818154 |
| 89 | GRK5 | 0.35623733 |
| 90 | INSR | 0.35381116 |
| 91 | CSNK1G3 | 0.35113950 |
| 92 | ATR | 0.33461510 |
| 93 | AURKA | 0.30927026 |
| 94 | PLK3 | 0.30326081 |
| 95 | CSNK2A1 | 0.30029100 |
| 96 | ABL1 | 0.29926120 |
| 97 | SCYL2 | 0.29552808 |
| 98 | MKNK2 | 0.27585597 |
| 99 | CSNK1G2 | 0.27083032 |
| 100 | ABL2 | 0.26620511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.65034804 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.01630254 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.46325315 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.15795934 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.94344805 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.84213447 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.73982155 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.68442387 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.57794959 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47010954 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.32947188 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.06055640 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.05524924 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.90575738 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86724035 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74445130 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73739111 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.72633105 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.70675011 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69046182 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.67789981 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.63810545 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.61205402 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.45528964 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42171951 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27006496 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17793370 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17246939 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16793337 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.16599934 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13820120 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.13766072 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13073141 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.01778082 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 0.98665632 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97741175 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95699176 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95074709 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94508417 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92081833 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91449641 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91253236 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90047693 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 0.86915624 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84315852 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81782196 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81684391 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77979794 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77895604 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75108350 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74412051 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.74107839 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.72401751 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71736615 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.70299383 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68703223 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68579987 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64005764 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63508354 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63437114 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62980411 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60648968 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.59841563 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59485384 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56819016 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54648907 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50982628 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50840672 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50658650 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49485421 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48257736 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46345941 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46303793 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46182176 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45521481 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45267392 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.41060790 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.40900280 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.38846788 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.37993039 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.36172312 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.35702488 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34493272 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34229604 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30852761 |
| 86 | Mismatch repair_Homo sapiens_hsa03430 | 0.27555254 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26700154 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25719068 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25530998 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.25482396 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.24608711 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.23402808 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.23270557 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22344465 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.17734080 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.17534694 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.16665045 |
| 98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.16455146 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.15849035 |
| 100 | GABAergic synapse_Homo sapiens_hsa04727 | 0.15375975 |

